Literature DB >> 21172512

Risk factor analysis of 170 single-institutional contegra implantations in pulmonary position.

Hitendu Dave1, Oliver Mueggler, Maurice Comber, Bassey Enodien, Georgios Nikolaou, Urs Bauersfeld, Rolf Jenni, Dominique Bettex, Rene Prêtre.   

Abstract

BACKGROUND: The aim of this study is to evaluate risk factors affecting survival of Contegra grafts used in the pulmonary position.
METHODS: One hundred seventy Contegra implanted (2001 to 2007) in the pulmonary position for replacement after a prior repair (90), Ross procedure (29), tetralogy of Fallot and variants (22), truncus arteriosus (13), Rastelli procedure (8), and miscellaneous (8) were reviewed. Median age was 107 (0.1 to 894) months. Follow-up was 96% complete with a median duration of 65 (7 to 98) months.
RESULTS: There were 7 early and 6 late deaths (none Contegra related) with a survival of 92%±2% at 98 months. Thirty-four Contegra were replaced at a median duration of 43 (7 to 82) months. Eight of 28 balloon-dilated Contegra remain palliated at 49 (23 to 73) months. Multivariate analysis showed Contegra less than 16 mm (p<0.001; HR [hazard ratio] 0.07), high pulmonary pressure (p<0.001; HR 4), and prior operation era (p=0.006; HR 0.3) as independent risk factors for Contegra replacement. The freedom from replacement for Contegra less than 16 mm and 16 mm or greater were 48%±8% and 98%±2%; for presence and absence of high pulmonary pressure were 52%±11% and 88%±3% and for era 1 and 2 were 77%±5% and 88%±4% at 60 months, respectively. Twenty-three of 123 surviving Contegra have a mean Doppler gradient greater than 20 mm Hg. Contegra less than 16 mm, smaller age group, obstructive arborization, and era 1 were significantly associated with higher gradients. While 18 (15%) surviving Contegra have moderate or more regurgitation, 88 (72%) have no significant gradient or regurgitation.
CONCLUSIONS: Contegra grafts integrate well into the body. Larger Contegra show predictable function with a survival approaching homografts over medium term. Better case selection as one ascends the learning curve tends to improve survival. With easy availability and predictable quality, Contegra grafts continue to be a promising complement to homografts.
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Mesh:

Year:  2011        PMID: 21172512     DOI: 10.1016/j.athoracsur.2010.07.058

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Early clinical outcomes of right ventricular outflow tract reconstruction with small caliber bovine jugular vein conduit (Contegra®) in small children.

Authors:  Takashi Kido; Takaya Hoashi; Koji Kagisaki; Toshiki Fujiyoshi; Masataka Kitano; Kenichi Kurosaki; Isao Shiraishi; Toshikatsu Yagihara; Yoshiki Sawa; Hajime Ichikawa
Journal:  J Artif Organs       Date:  2016-05-28       Impact factor: 1.731

2.  Mid-term Outcome of 100 Consecutive Ross Procedures: Excellent Survival, But Yet to Be a Cure.

Authors:  Corina Zimmermann; Christine Attenhofer Jost; René Prêtre; Christoph Mueller; Matthias Greutmann; Burkhardt Seifert; Emanuela Valsangiacomo Büchel; Oliver Kretschmar; Hitendu Hasmukhlal Dave; Roland Weber
Journal:  Pediatr Cardiol       Date:  2018-01-12       Impact factor: 1.655

3.  Dilatation and Dysfunction of the Neo-aortic Root and in 76 Patients After the Ross Procedure.

Authors:  Corina A Zimmermann; Roland Weber; Matthias Greutmann; Hitendu Dave; Christoph Müller; René Prêtre; Burkhardt Seifert; Emanuela Valsangiacomo Buechel; Oliver Kretschmar; Christine H Attenhofer Jost
Journal:  Pediatr Cardiol       Date:  2016-06-14       Impact factor: 1.655

Review 4.  Current status of right ventricular outflow tract reconstruction: complete translation of a review article originally published in Kyobu Geka 2014;67:65-77.

Authors:  Yusuke Yamamoto; Masaaki Yamagishi; Takako Miyazaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-12-13

5.  Mid-term outcomes of Contegra implantation for the reconstruction of the right ventricular outflow tract to proximal branch pulmonary arteries: Japan multicentre study.

Authors:  Takaya Hoashi; Hajime Ichikawa; Keiichi Hirose; Naohiro Horio; Takahisa Sakurai; Hironori Matsuhisa; Yoshihiro Ohsima; Hajime Sakurai; Shingo Kasahara; Kisaburo Sakamoto
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-07-26

6.  Melody valve to replace the mitral valve in small children: Lessons learned.

Authors:  Vilius Dranseika; Rene Pretre; Oliver Kretschmar; Hitendu Dave
Journal:  Ann Pediatr Cardiol       Date:  2021-01-04

7.  Risk factors for early adverse outcomes after bovine jugular vein conduit implantation: influence of oversized conduit on the outcomes.

Authors:  Dong-Hee Kim; Young Kern Kwon; Eun Seok Choi; Bo Sang Kwon; Chun Soo Park; Tae-Jin Yun
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-09-09

8.  Outcomes of truncus arteriosus repair with bovine jugular vein conduit.

Authors:  Ersin Erek; Bahar Temur; Dilek Suzan; Selim Aydın; Okan Yıldız; Barış Kırat; İbrahim Halil Demir; Ender Ödemiş
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-07-03       Impact factor: 0.332

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.